JP2014513983A5 - - Google Patents

Download PDF

Info

Publication number
JP2014513983A5
JP2014513983A5 JP2014510518A JP2014510518A JP2014513983A5 JP 2014513983 A5 JP2014513983 A5 JP 2014513983A5 JP 2014510518 A JP2014510518 A JP 2014510518A JP 2014510518 A JP2014510518 A JP 2014510518A JP 2014513983 A5 JP2014513983 A5 JP 2014513983A5
Authority
JP
Japan
Prior art keywords
cells
zscan4
seq
reprogramming
contacting
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2014510518A
Other languages
English (en)
Japanese (ja)
Other versions
JP2014513983A (ja
JP6189829B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2012/037643 external-priority patent/WO2012158561A1/en
Publication of JP2014513983A publication Critical patent/JP2014513983A/ja
Publication of JP2014513983A5 publication Critical patent/JP2014513983A5/ja
Application granted granted Critical
Publication of JP6189829B2 publication Critical patent/JP6189829B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2014510518A 2011-05-13 2012-05-11 Zscan4とzscan4依存性遺伝子を利用した体細胞の直接的な再プログラム化 Active JP6189829B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201161486004P 2011-05-13 2011-05-13
US61/486,004 2011-05-13
US201161529055P 2011-08-30 2011-08-30
US61/529,055 2011-08-30
PCT/US2012/037643 WO2012158561A1 (en) 2011-05-13 2012-05-11 Use of zscan4 and zscan4-dependent genes for direct reprogramming of somatic cells

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2017108578A Division JP2017212985A (ja) 2011-05-13 2017-05-31 Zscan4とzscan4依存性遺伝子を利用した体細胞の直接的な再プログラム化

Publications (3)

Publication Number Publication Date
JP2014513983A JP2014513983A (ja) 2014-06-19
JP2014513983A5 true JP2014513983A5 (enExample) 2015-07-16
JP6189829B2 JP6189829B2 (ja) 2017-08-30

Family

ID=47177285

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2014510518A Active JP6189829B2 (ja) 2011-05-13 2012-05-11 Zscan4とzscan4依存性遺伝子を利用した体細胞の直接的な再プログラム化
JP2017108578A Pending JP2017212985A (ja) 2011-05-13 2017-05-31 Zscan4とzscan4依存性遺伝子を利用した体細胞の直接的な再プログラム化

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2017108578A Pending JP2017212985A (ja) 2011-05-13 2017-05-31 Zscan4とzscan4依存性遺伝子を利用した体細胞の直接的な再プログラム化

Country Status (6)

Country Link
US (1) US9932560B2 (enExample)
EP (1) EP2707479B1 (enExample)
JP (2) JP6189829B2 (enExample)
AU (1) AU2012256014B2 (enExample)
CA (1) CA2835825C (enExample)
WO (1) WO2012158561A1 (enExample)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2835825C (en) 2011-05-13 2021-03-23 Minoru S.H. Ko Use of zscan4 and zscan4-dependent genes for direct reprogramming of somatic cells
RU2735141C2 (ru) * 2013-03-15 2020-10-28 Иликсиэджен Терапьютикс, Инк. Способы применения zscan4 для омоложения человеческих клеток
US20170327796A1 (en) * 2014-12-18 2017-11-16 University Of Utah Research Foundation Induced pluripotent stem cell and method for producing the same
CN105219729B (zh) * 2015-09-28 2018-09-25 首都医科大学宣武医院 一种利用非整合质粒载体诱导神经干细胞的方法及其用途
CN106800590B (zh) * 2015-11-25 2021-04-09 杭州智鹤丹谷生物医药有限公司 一种结合多种淀粉样蛋白单体和聚集体的多肽及其应用
CA3046660C (en) * 2016-12-15 2026-01-27 Illumina, Inc. Methods and systems for determining paralogs
CN107475378B (zh) * 2017-08-03 2021-03-30 复旦大学 用于检测女性原发不孕的patl2基因及检测该基因突变的试剂盒
US20200224172A1 (en) * 2017-09-19 2020-07-16 The Broad Institute, Inc. Methods and systems for reconstruction of developmental landscapes by optimal transport analysis
CN107988147B (zh) * 2017-12-19 2021-11-09 江汉大学 基于器官芯片与诱导多能干细胞的定向分化用于3d拟表皮构建的方法
WO2020237209A1 (en) * 2019-05-22 2020-11-26 University Of Maryland, Baltimore Methods of treating cancer by targeting zscan4 activity in cancer stem cells
CN110616232B (zh) * 2019-09-23 2023-04-11 中国人民解放军陆军军医大学 Sox30敲除和可恢复型小鼠动物模型构建方法及应用
EP4061833A4 (en) * 2019-11-22 2023-09-06 Alcamen Stem Cell Therapeutics, LLC COMPOSITIONS AND METHODS FOR DEREPRESSION OF RE1 SILENCING TRANSCRIPTION FACTOR TARGET GENES

Family Cites Families (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4980289A (en) 1987-04-27 1990-12-25 Wisconsin Alumni Research Foundation Promoter deficient retroviral vector
US5888762A (en) 1990-06-05 1999-03-30 Centre National De La Recherche Scientifique (Cnrs) Neurotropic growth factors comprising a homeobox peptide
KR100201352B1 (ko) 1995-03-16 1999-06-15 성재갑 단일주사 백신 제형
US7198784B2 (en) 1996-10-17 2007-04-03 Oxford Biomedica (Uk) Limited Retroviral vectors
FR2762615B1 (fr) 1997-04-28 1999-07-16 Inst Nat Sante Rech Med Nouveau site interne d'entree des ribosomes et vecteur le contenant
AU5250100A (en) 1999-06-22 2001-01-09 Dnavec Research Inc. Vector for expressing two foreign genes
US20110171185A1 (en) * 1999-06-30 2011-07-14 Klimanskaya Irina V Genetically intact induced pluripotent cells or transdifferentiated cells and methods for the production thereof
DE19933492B4 (de) 1999-07-16 2008-01-10 Deutsches Krebsforschungszentrum Stiftung des öffentlichen Rechts Konjugat zur Vermittlung eines zell-, kompartiment- oder membranspezifischen Transports von Wirksubstanzen, Verfahren zu dessen Herstellung und dessen Verwendung
CA2392490A1 (en) 1999-11-24 2001-05-31 Mcs Micro Carrier Systems Gmbh Polypeptides comprising multimers of nuclear localization signals or of protein transduction domains and their use for transferring molecules into cells
US7211247B2 (en) 2001-04-09 2007-05-01 University Of Southern California Lentivirus vectors for gene transfer to alveolar epithelial cells
US7081489B2 (en) 2001-08-09 2006-07-25 Florida State University Research Foundation Polymeric encapsulation of nanoparticles
US20040014209A1 (en) 2002-01-23 2004-01-22 Lassar Andrew B. Compositions and methods for modulating cell differentiation
US7354763B2 (en) 2002-04-16 2008-04-08 Technion Research & Development Foundation Ltd. Generating vascular smooth muscle cells in vitro from ES cells
EP2116604A1 (en) 2002-08-05 2009-11-11 University of Rochester Protein transducing domain/deaminase chimeric proteins, related compounds, and uses thereof
KR100591936B1 (ko) 2002-11-12 2006-06-22 포휴먼텍(주) 세포내 dna/rna 전달 방법, 및 이것의 기초 및임상학적 응용
CA2516116A1 (en) 2003-01-16 2004-08-05 St. John's University Nanoparticle based stabilization of ir fluorescent dyes
US7166692B2 (en) 2003-03-04 2007-01-23 Canbrex Bio Science Walkersville, Inc. Intracellular delivery of small molecules, proteins, and nucleic acids
US7682828B2 (en) 2003-11-26 2010-03-23 Whitehead Institute For Biomedical Research Methods for reprogramming somatic cells
AU2005207042B2 (en) 2004-01-23 2010-09-09 President And Fellows Of Harvard College Improved modalities for the treatment of degenerative diseases of the retina
US20080260851A1 (en) 2004-05-13 2008-10-23 The Trustees Of Columbia University In The City Of New York Polymeric Nanoparticles and Nanogels for Extraction and Release of Compounds
US20060024331A1 (en) 2004-08-02 2006-02-02 Ester Fernandez-Salas Toxin compounds with enhanced membrane translocation characteristics
CA2613812A1 (en) 2005-01-31 2006-08-10 Es Cell International Pte Ltd. Directed differentiation of embryonic stem cells and uses thereof
ATE382337T1 (de) 2005-04-28 2008-01-15 Nipro Corp Bioabsorbierbare pharmazeutische zusammensetzung enthaltend einen plga-copolymer
AU2006244135A1 (en) 2005-05-10 2006-11-16 Naomi Balaban Compositions for administering RNAIII-inhibiting peptides
CN101864392B (zh) 2005-12-13 2016-03-23 国立大学法人京都大学 核重新编程因子
US20090227032A1 (en) 2005-12-13 2009-09-10 Kyoto University Nuclear reprogramming factor and induced pluripotent stem cells
US8278104B2 (en) 2005-12-13 2012-10-02 Kyoto University Induced pluripotent stem cells produced with Oct3/4, Klf4 and Sox2
EP2129771B1 (en) * 2007-03-26 2018-09-12 The Government of the U.S.A. as represented by the Secretary of the Department of Health & Human Services Methods for modulating embryonic stem cell differentiation
CN101855350B (zh) 2008-05-02 2014-12-31 国立大学法人京都大学 核重编程序方法
JP5785948B2 (ja) 2009-09-04 2015-09-30 ザ ユナイテッド ステイツ オブ アメリカ, アズ リプレゼンテッド バイ ザ セクレタリー, デパートメント オブ ヘルス アンド ヒューマン サービシーズ 胚性幹細胞におけるゲノムの安定性およびテロメアの伸長を促進するための方法
EP2689022B1 (en) 2011-03-23 2018-04-25 The United States of America, as represented by The Secretary, Department of Health and Human Services Compositions and methods for enhancing the pluripotency of stem cells
CA2835825C (en) 2011-05-13 2021-03-23 Minoru S.H. Ko Use of zscan4 and zscan4-dependent genes for direct reprogramming of somatic cells

Similar Documents

Publication Publication Date Title
JP7022878B2 (ja) 細胞リプログラミング
Ratajczak et al. A novel view of the adult stem cell compartment from the perspective of a quiescent population of very small embryonic-like stem cells
Lee et al. iPSC-derived MSCs are a distinct entity of MSCs with higher therapeutic potential than their donor-matched parental MSCs
Roubelakis et al. Amniotic fluid and amniotic membrane stem cells: marker discovery
EP2826855B1 (en) Myocardial sheet
KR101686722B1 (ko) 신경줄기세포 제조를 위한 배지와 그의 용도
CN102844428B (zh) Ets2和mesp1由成纤维细胞生成心脏祖细胞
Abu Kasim et al. Unique molecular signatures influencing the biological function and fate of post‐natal stem cells isolated from different sources
US20150232810A1 (en) Methods of preparing pluripotent stem cells
JP6373253B2 (ja) 新規心筋細胞マーカー
US20140093481A1 (en) Production of dentin, cementum and enamel by cells
JP6025067B2 (ja) 新規心筋細胞マーカー
JP2011068660A5 (enExample)
WO2019237124A1 (en) Next generation designer liver organoids and their methods of preparation and use
AU2018286654A1 (en) Cell reprogramming to cardiomyocytes
Zhao et al. Heparan Sulfate Chain‐Conjugated Laminin‐E8 Fragments Advance Paraxial Mesodermal Differentiation Followed by High Myogenic Induction from hiPSCs
JP2012532592A5 (enExample)
Gao et al. A plethora of human pluripotent stem cells
Sun et al. MiR-98-5p regulates myocardial differentiation of mesenchymal stem cells by targeting TBX5.
CN102628029B (zh) 地贫诱导多能干细胞及其制备方法和用途
KR20230113768A (ko) 유도 줄기 세포
JPWO2016114341A1 (ja) 多能性細胞識別化合物
CN104450622A (zh) 一种重组细胞系、其制备方法和应用
Caulier et al. Targeted release of transcription factors for human cell reprogramming by ZEBRA cell-penetrating peptide
Paulitschek et al. Generation and characterization of two iPSC lines from human epicardium-derived cells